Literature DB >> 7475141

Completion pneumonectomy: indications and outcome.

K al-Kattan1, P Goldstraw.   

Abstract

Completion pneumonectomy has been associated with higher rates of morbidity and mortality and this is reflected in the selection of cases and the indications for the procedure. During a period of 14 years from January 1980 to November 1993, 38 completion pneumonectomies were done by our surgical team, representing 5.1% of all pneumonectomies. There were 24 right and 14 left completion pneumonectomies done in 26 male and 12 female patients with an average age of 61 years (range from 29 to 77 years). Lung malignancy accounted for 26 of these cases in which the indication included local recurrence in 10, second primary tumor in 9, malignancy that developed after resection for benign disease in 2, and pulmonary metastasectomy in 5 cases. Benign diseases were the indication in 12 cases: tuberculosis in 4, bronchiectasis in 4, aspergillosis in 1, and postoperative complications in 3. Additional surgical procedures were necessary in 7 cases: chest wall resection with insertion of prosthesis in 3, thoracoplasty in 2, and omental flap in 2. There was 1 early postoperative death after 5 weeks from adult respiratory distress syndrome. There was no occurrence of bronchopleural fistula, and the 18% associated morbidity rate was a result of bleeding necessitating reexploration in 3 cases, prolonged ventilation in 2, and chronic empyema in 2. Six of these complications (86%) occurred in the group with benign disease. Completion pneumonectomy can be done with an acceptable morbidity in selected patients. Careful technique is important to secure hemostasis and to avoid fistulas. The complication rate is higher when infective disease is involved.

Entities:  

Mesh:

Year:  1995        PMID: 7475141     DOI: 10.1016/s0022-5223(05)80182-5

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Completion pneumonectomy for recurrent or second primary lung cancer.

Authors:  M Muraoka; T Oka; T Takahashi; S Akamine; M Morinaga; T Nagayasu; Y Tagawa; H Ayabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-07

2.  [Completion pneumonectomy. Indications and results].

Authors:  W Jungraithmayr; J Hasse; M Olschewski; E Stoelben
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

3.  Completion pneumonectomy: a valuable option for lung cancer recurrence or new primaries.

Authors:  Dragan Subotic; Laureano Molins; Ivan Soldatovic; Dejan Moskovljevic; Lucia Collado; Jorge Hernández
Journal:  World J Surg Oncol       Date:  2018-05-28       Impact factor: 2.754

4.  Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.

Authors:  Serkan Yazgan; Ahmet Üçvet; Soner Gürsoy; Özgür Samancılar
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

5.  Completion pneumonectomy for lung cancer treatment: early and long term outcomes.

Authors:  Peng Zhang; Chao Jiang; Wenxin He; Nan Song; Xiao Zhou; Gening Jiang
Journal:  J Cardiothorac Surg       Date:  2012-10-09       Impact factor: 1.637

6.  Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience.

Authors:  Shakil Farid; Shaza Mohamed; Mohan Devbhandari; Matthew Kneale; Malcolm Richardson; Sing Y Soon; Mark T Jones; Piotr Krysiak; Rajesh Shah; David W Denning; Kandadai Rammohan
Journal:  J Cardiothorac Surg       Date:  2013-08-05       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.